Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > The bones are telling me an 8.00 US offer is coming soon .
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(633)
•••
Comment by 99942Apophison Feb 09, 2022 10:30am
507 Views
Post# 34412227

RE:RE:RE:RE:RE:The bones are telling me an 8.00 US offer is coming soon .

RE:RE:RE:RE:RE:The bones are telling me an 8.00 US offer is coming soon .
pullsea wrote

My first Criticism is any response, agreements or disagreements, should be termed CRITIQUE... sounds absolutely positive. Second comment is "good hypothetical analysis". Third, why are we looking for $8 offer when we see a potential $112 :-)

Hi pullsea, that heading was under a fellow poster who thought a buyout for 8 dollars was fair starting point. I posted my guesstimate based on possible revenue stream in the first full year of commercialization to point out if a buyout were offered it should carry something much higher than a projected share price.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities